Sialylation patterns in cerebral amyloid angiopathy
Brain Pathology · 2026
DOI: 10.1111/bpa.70042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Pathology, 2026. Verfasst von Caitlyn Fastenau und 8 weiteren Autor:innen. Beteiligte Einrichtung: Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: Cerebral Amyloid Angiopathy, Alzheimer Disease, N-Acetylneuraminic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, Texas Alzheimer's Research and Care Consortium, NIH HHS.
Abstract (Originalsprache)
Glycosylation is the most common form of post‐translational modification in the brain and becomes significantly altered in the context of neurodegeneration. One notable alteration is an enrichment of terminal sialic acid (SA) modifications. Previous studies provide evidence of increased sialylation on microglia, the innate immune cell of the brain, in Alzheimer's disease (AD), particularly near amyloid beta plaques. Yet, there is little understanding of the relationship between SA and other amyloid beta‐related diseases like Cerebral Amyloid Angiopathy (CAA). Nearly half of all AD cases have CAA; thus, it is critical to understand the relationship between amyloid pathology and SA modifications. The present study aimed to overcome this gap in knowledge by investigating sialylation patterns in AD cases with CAA compared with CAA‐negative AD cases and amyloid‐negative control cases. The localization of SA modifications was investigated in the frontal cortex of 30 post‐mortem cases with or without diagnoses of AD and/or CAA. Quantitative digital pathology analyses were used to determine regional SA differences in parenchymal and leptomeningeal blood vessels. First, we found no difference in intravascular amyloid‐beta levels between the parenchymal and leptomeningeal vessels of AD with CAA cases, suggesting no regional differences in this amyloid aggregation. Next, there was a visual increase in microglia sialylation surrounding parenchymal blood vessels in the CAA cases. Notably, there were significant differences in intravascular SA levels across the three comparison groups. AD cases with CAA had significantly greater sialylation levels in both the parenchymal and leptomeningeal vessels compared with the AD‐only and control groups. This is a novel finding that supports the consideration of glycosylation changes that contribute to worse pathological outcomes in AD with CAA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
- Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
- Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
- Neuropathology Brain Bank & Research CoRE, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Caitlyn Fastenau, Sarah C Hopp
Förderung
- NIA NIH HHS
- Texas Alzheimer's Research and Care Consortium
- NIH HHS
- NIGMS NIH HHS
- Bartell and Mollie Zachry Endowment for Alzheimer's Research and Patient Care
- NINDS NIH HHS
- National Institutes of Health
- National Institute of General Medical Sciences
Zitieren
APA
Fastenau, C., Crisp, R., Keating, M., Ochoa, E., Richardson, T. E., Flanagan, M. E., Walker, J. M., Hopp, S. C., & Bieniek, K. F. (2026). Sialylation patterns in cerebral amyloid angiopathy. Brain Pathology. https://doi.org/10.1111/bpa.70042
Vancouver
Fastenau C, Crisp R, Keating M, Ochoa E, Richardson TE, Flanagan ME, et al. Sialylation patterns in cerebral amyloid angiopathy. Brain Pathology. 2026. doi:10.1111/bpa.70042
BibTeX
@article{Fastenau2026,
author = {Fastenau, Caitlyn and Crisp, Rebecca and Keating, Mallory and Ochoa, Elizabeth and Richardson, Timothy E and Flanagan, Margaret E and Walker, Jamie M and Hopp, Sarah C and Bieniek, Kevin F},
title = {Sialylation patterns in cerebral amyloid angiopathy},
journal = {Brain Pathology},
year = {2026},
doi = {10.1111/bpa.70042}
}
EUVIMED